Global DNA Microarray Market - Analysis, Technologies & Forecasts to 2020 - Key Vendors are Agilent Technologies, Illumina & Merck - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global DNA Microarray Market 2016-2020" report to their offering.

The report forecasts the global DNA microarray market to grow at a CAGR of 15.16% during the period 2016-2020.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, advances in technology will be a key driver for market growth. Rapid advances in technology related to DNA microarray has equipped related solutions to produce results with high efficiency, accuracy, specificity, and reproducibility in target identification, primary screening, and toxicity study in drug discovery and research. The technological advances in DNA microarray have also enabled solutions to be applied in clinics, commercial laboratories and research institutions, and hospitals to detect DNA and proteins with the motive of disease diagnosis, drug discovery, and disease monitoring that has significantly increased the acceptance and adoption of these solutions.

Further, the report states that the laws and regulations of the approval process for diagnostic devices vary across all countries, which is a major challenge faced by MNCs.

Key vendors:

• Agilent Technologies
• Illumina
• Merck
• Thermo Fisher Scientific

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Market segmentation by product type

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

For more information on this topic, check out the Pharmaceuticals and Healthcare section of the Research and Markets' blog.

For more information about this report visit http://www.researchandmarkets.com/research/96txl7/global_dna